11-72294395-T-G
Variant summary
Our verdict is Likely pathogenic. The variant received 8 ACMG points: 8P and 0B. PM1PM2PM5PP3_Moderate
The NM_030813.6(CLPB):c.1700A>C(p.Tyr567Ser) variant causes a missense change involving the alteration of a conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a pathogenic outcome for this variant. 13/22 in silico tools predict a damaging outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. Y567C) has been classified as Likely pathogenic.
Frequency
Consequence
NM_030813.6 missense
Scores
Clinical Significance
Conservation
Publications
- 3-methylglutaconic aciduria, type VIIBInheritance: AR Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Orphanet, G2P, Ambry Genetics, Labcorp Genetics (formerly Invitae)
- neutropenia, severe congenital, 9, autosomal dominantInheritance: AD Classification: STRONG Submitted by: Labcorp Genetics (formerly Invitae)
- Leigh syndromeInheritance: AR Classification: LIMITED Submitted by: ClinGen
Genome browser will be placed here
ACMG classification
Our verdict: Likely_pathogenic. The variant received 8 ACMG points.
Variant Effect in Transcripts
ACMG analysis was done for transcript: NM_030813.6. You can select a different transcript below to see updated ACMG assignments.
RefSeq Transcripts
| Selected | Gene | Transcript | Tags | HGVSc | HGVSp | Effect | Exon Rank | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|---|
| CLPB | NM_030813.6 | MANE Plus Clinical | c.1700A>C | p.Tyr567Ser | missense | Exon 15 of 17 | NP_110440.1 | ||
| CLPB | NM_001258392.3 | MANE Select | c.1610A>C | p.Tyr537Ser | missense | Exon 14 of 16 | NP_001245321.1 | ||
| CLPB | NM_001258394.3 | c.1565A>C | p.Tyr522Ser | missense | Exon 16 of 18 | NP_001245323.1 |
Ensembl Transcripts
| Selected | Gene | Transcript | Tags | HGVSc | HGVSp | Effect | Exon Rank | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|---|
| CLPB | ENST00000294053.9 | TSL:1 MANE Plus Clinical | c.1700A>C | p.Tyr567Ser | missense | Exon 15 of 17 | ENSP00000294053.3 | ||
| CLPB | ENST00000538039.6 | TSL:2 MANE Select | c.1610A>C | p.Tyr537Ser | missense | Exon 14 of 16 | ENSP00000441518.1 | ||
| CLPB | ENST00000538021.5 | TSL:1 | n.*399A>C | non_coding_transcript_exon | Exon 7 of 9 | ENSP00000445180.2 |
Frequencies
GnomAD3 genomes Cov.: 33
GnomAD4 exome Cov.: 32
GnomAD4 genome Cov.: 33
ClinVar
Submissions by phenotype
3-methylglutaconic aciduria, type VIIB Uncertain:1
This sequence change replaces tyrosine, which is neutral and polar, with serine, which is neutral and polar, at codon 567 of the CLPB protein (p.Tyr567Ser). This variant is not present in population databases (gnomAD no frequency). This missense change has been observed in individual(s) with 3-methylglutaconic aciduria (PMID: 32219827). ClinVar contains an entry for this variant (Variation ID: 1045621). An algorithm developed to predict the effect of missense changes on protein structure and function (PolyPhen-2) suggests that this variant is likely to be disruptive. This variant disrupts the p.Tyr567 amino acid residue in CLPB. Other variant(s) that disrupt this residue have been determined to be pathogenic (PMID: 25597510). This suggests that this residue is clinically significant, and that variants that disrupt this residue are likely to be disease-causing. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance.
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at